JNCI-Journal of the National Cancer Institute

Article	Citations
Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group	370
Annual Report to the Nation on the Status of Cancer, Part 1: National Cancer Statistics	304
Atezolizumab and nab-Paclitaxel in Advanced Triple-Negative Breast Cancer: Biomarker Evaluation of the IMpassion130 Study	189
Therapy-Induced Senescence: Opportunities to Improve Anticancer Therapy	182
Clinical Characteristics and Outcomes of COVID-19–Infected Cancer Patients: A Systematic Review and Meta-Analysis	147
Real-World Effectiveness of Human Papillomavirus Vaccination Against Cervical Cancer	141
The Incidence of Breast Cancer Recurrence 10-32 Years After Primary Diagnosis	138
State Variation in Low-Dose Computed Tomography Scanning for Lung Cancer Screening in the United States	135
Annual Report to the Nation on the Status of Cancer, Part 2: Patient Economic Burden Associated With Cancer Care	110
Precision Radiotherapy: Reduction in Radiation for Oropharyngeal Cancer in the 30 ROC Trial	108
Impact of the COVID-19 Pandemic on Breast Cancer Mortality in the US: Estimates From Collaborative Simulation Modeling	103
Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic EGFR-Mutated Non-Small Cell Lung Cancer	98
Cancer Misinformation and Harmful Information on Facebook and Other Social Media: A Brief Report	95
A Comprehensive Comparison of Early-Onset and Average-Onset Colorectal Cancers	95
PD-L1 Immunohistochemistry Assay Comparison in Atezolizumab Plus nab-Paclitaxel–Treated Advanced Triple-Negative Breast Cancer	91
Clinical Value of Consensus Molecular Subtypes in Colorectal Cancer: A Systematic Review and Meta-Analysis	90
Cancer Stage, Treatment, and Survival Among Transgender Patients in the United States	88
Using Prediction Models to Reduce Persistent Racial and Ethnic Disparities in the Draft 2020 USPSTF Lung Cancer Screening Guidelines	83
Estimation of the Number of Individuals Living With Metastatic Cancer in the United States	82
Comprehensive Assessment of Diet Quality and Risk of Precursors of Early-Onset Colorectal Cancer	74
Association of the COVID-19 Pandemic With Patterns of Statewide Cancer Services	73
Changes in Mammography Use by Women’s Characteristics During the First 5 Months of the COVID-19 Pandemic	72
Rural–Urban Disparities in Cancer Outcomes: Opportunities for Future Research	72
Germline Cancer Predisposition Variants in  Pediatric Rhabdomyosarcoma: A Report From the Children’s Oncology Group	66
Evidence Gaps in Cancer Survivorship Care: A Report From the 2019 National Cancer Institute Cancer Survivorship Workshop	66

Long-Term Cause-Specific Mortality in Hodgkin Lymphoma Patients	61
Immunogenicity and Safety of the BNT162b2 mRNA COVID-19 Vaccine Among Actively Treated Cancer Patients	60
Association Between Sex and Immune-Related Adverse Events During Immune Checkpoint Inhibitor Therapy	59
Association of Obesity With Breast Cancer Outcome in Relation to Cancer Subtypes: A Meta-Analysis	57
Measuring Self-Reported Cancer-Related Cognitive Impairment: Recommendations From the Cancer Neuroscience Initiative Working Group	57
Racial and Ethnic Variation in PSA Testing and Prostate Cancer Incidence Following the 2012 USPSTF Recommendation	54
Breast Tumor Microenvironment in Black Women: A Distinct Signature of CD8+ T-Cell Exhaustion	54
Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort Study	53
Performance of Digital Breast Tomosynthesis, Synthetic Mammography, and Digital Mammography in Breast Cancer Screening: A Systematic Review and Meta-Analysis	53
Prevalence and Prognosis of Lynch Syndrome and Sporadic Mismatch Repair Deficiency in Endometrial Cancer	52
Survivorship for Individuals Living With Advanced and Metastatic Cancers: National Cancer Institute Meeting Report	49
The Mortality and Overall Survival Trends of Primary Liver Cancer in the United States	48
Associations Between Glycemic Traits and Colorectal Cancer: A Mendelian Randomization Analysis	48
Medical Financial Hardship in Survivors of Adolescent and Young Adult Cancer in the United States	47
Evaluating Polygenic Risk Scores for Breast Cancer in Women of African Ancestry	46
Cost-Effectiveness of Magnetic Resonance Imaging Screening for Women With Extremely Dense Breast Tissue	45
KRAS and BRAF Mutations in Stage II and III Colon Cancer: A Systematic Review and Meta-Analysis	45
Evaluation of a Multiethnic Polygenic Risk Score Model for Prostate Cancer	44
Disparities in Cancer Survival Among Adolescents and Young Adults: A Population-Based Study of 88 000 Patients	42
Identifying Novel Causes of Cancers to Enhance Cancer Prevention: New Strategies Are Needed	42
Systemic or Vaginal Hormone Therapy After Early Breast Cancer: A Danish Observational Cohort Study	42
Early-Onset Pancreas Cancer: Clinical Descriptors, Genomics, and Outcomes	41
Real-World Effectiveness of Human Papillomavirus Vaccination Against Vulvovaginal High-Grade Precancerous Lesions and Cancers	40
Poverty and Targeted Immunotherapy: Survival in Children’s Oncology Group Clinical Trials for High-Risk Neuroblastoma	40
Association of Medical Financial Hardship and Mortality Among Cancer Survivors in the United States	37
Targeted eHealth Intervention to Reduce Breast Cancer Survivors’ Fear of Recurrence: Results From the FoRtitude Randomized Trial	37
Neoadjuvant Immunotherapy for High-Risk, Resectable Malignancies: Scientific Rationale and Clinical Challenges	37
Use of Straighteners and Other Hair Products and Incident Uterine Cancer	36
Site of Recurrence and Survival After Surgery for Colorectal Peritoneal Metastasis	36
Homologous Recombination Deficiency Alterations in Colorectal Cancer: Clinical, Molecular, and Prognostic Implications	36
Body Mass Index and Risk of Second Cancer Among Women With Breast Cancer	36
Deficit Accumulation Frailty Trajectories of Older Breast Cancer Survivors and Non-Cancer Controls: The Thinking and Living With Cancer Study	35
Antibiotics Use and Subsequent Risk of Colorectal Cancer: A Swedish Nationwide Population-Based Study	34
Cost-Effectiveness of Smoking Cessation Interventions in the Lung Cancer Screening Setting: A Simulation Study	34
Side Effects 15 Years After Lymph Node Irradiation in Breast Cancer: Randomized EORTC Trial 22922/10925	34
CD4/CD8 Ratio and Cancer Risk Among Adults With HIV	32
Determining PD-L1 Status in Patients With Triple-Negative Breast Cancer: Lessons Learned From IMpassion130	32
Epigenetic Profiling and Response to CD19 Chimeric Antigen Receptor T-Cell Therapy in B-Cell Malignancies	32
Enduring Cancer Disparities by Persistent Poverty, Rurality, and Race: 1990-1992 to 2014-2018	32
Cellular Telephone Use and the Risk of Brain Tumors: Update of the UK Million Women Study	32
S1417CD: A Prospective Multicenter Cooperative Group-Led Study of Financial Hardship in Metastatic Colorectal Cancer Patients	31
Gender Differences in Treatment Allocation and Survival of Advanced Gastroesophageal Cancer: A Population-Based Study	31
Addressing Transportation Insecurity Among Patients With Cancer	31
Smoking History as a Potential Predictor of Immune Checkpoint Inhibitor Efficacy in Metastatic Non-Small Cell Lung Cancer	31
Smoking Cessation Prevalence and Inequalities in the United States: 2014-2019	31
Multicancer Early Detection: Learning From the Past to Meet the Future	30
Underreporting of Symptomatic Adverse Events in Phase I Clinical Trials	30
Increased CD8+ T-cell Infiltration and Efficacy for Multikinase Inhibitors After PD-1 Blockade in Hepatocellular Carcinoma	30
The Role of Mendelian Randomization Studies in Deciphering the Effect of Obesity on Cancer	29
Counts, incidence rates, and trends of pediatric cancer in the United States, 2003-2019	29

Clinicopathological Features and Outcomes Comparing Patients With Invasive Ductal and Lobular Breast Cancer	29
Racial Disparities in Recurrence and Overall Survival in Patients With Locoregional Colorectal Cancer	29
Wedding of Molecular Alterations and Immune Checkpoint Blockade: Genomics as a Matchmaker	29
An Artificial Intelligence System for the Detection of Bladder Cancer via Cystoscopy: A Multicenter Diagnostic Study	29
NDRG1 in Aggressive Breast Cancer Progression and Brain Metastasis	28
Association Between Medicaid Expansion Under the Affordable Care Act and Survival Among Newly Diagnosed Cancer Patients	28
Deep Learning vs Traditional Breast Cancer Risk Models to Support Risk-Based Mammography Screening	28
An Imaging Biomarker of Tumor-Infiltrating Lymphocytes to Risk-Stratify Patients With HPV-Associated Oropharyngeal Cancer	27
The Oral Microbiome and Lung Cancer Risk: An Analysis of 3 Prospective Cohort Studies	27
Cost-Effectiveness of Nasopharyngeal Carcinoma Screening With Epstein-Barr Virus Polymerase Chain Reaction or Serology in High-Incidence Populations Worldwide	27
Survival in Young-Onset Metastatic Colorectal Cancer: Findings From Cancer and Leukemia Group B (Alliance)/SWOG 80405	27
Incidence of Lung Cancer Among Never-Smoking Asian American, Native Hawaiian, and Pacific Islander Females	27
Cumulative Advanced Breast Cancer Risk Prediction Model Developed in a Screening Mammography Population	27
Clinicopathological and Molecular Characteristics of Early-Onset Stage III Colon Adenocarcinoma: An Analysis of the ACCENT Database	26
BRAFV600E Mutation in First-Line Metastatic Colorectal Cancer: An Analysis of Individual Patient Data From the ARCAD Database	26
Timing of Aspirin Use in Colorectal Cancer Chemoprevention: A Prospective Cohort Study	26
Performance of Breast Cancer Polygenic Risk Scores in 760 FemaleCHEK2Germline Mutation Carriers	26
Concordance Between Tumor and Germline BRCA Status in High-Grade Ovarian Carcinoma Patients in the Phase III PAOLA-1/ENGOT-ov25 Trial	26
Early Medicaid Expansion and Cancer Mortality	26
Heterozygous BRCA1 and BRCA2 and Mismatch Repair Gene Pathogenic Variants in Children and Adolescents With Cancer	25
Overcoming the challenges to implementation of artificial intelligence in pathology	25
Readdressing the Needs of Cancer Survivors During COVID-19: A Path Forward	25
Interventions to improve outcomes for caregivers of patients with advanced cancer: a meta-analysis	25
Quality of Life in Older Adults After Major Cancer Surgery: The GOSAFE International Study	25
Addressing Complementary and Alternative Medicine Use Among Individuals With Cancer: An Integrative Review and Clinical Practice Guideline	24
Advanced Breast Cancer Definitions by Staging System Examined in the Breast Cancer Surveillance Consortium	24
Racial Disparities in Epigenetic Aging of the Right vs Left Colon	24
Patient-Reported Outcomes in Clinical Trials Leading to Cancer Immunotherapy Drug Approvals From 2011 to 2018: A Systematic Review	24
Long-Term Colorectal Cancer Incidence and Mortality After Colonoscopy Screening According to Individuals’ Risk Profiles	24
Glyphosate exposure and urinary oxidative stress biomarkers in the Agricultural Health Study	24
The Impact of Intensifying Prostate Cancer Screening in Black Men: A Model-Based Analysis	24
Housing Insecurity Among Patients With Cancer	24
Age Is Just a Number: Considerations for Older Adults in Cancer Clinical Trials	23
Associations of Aspirin and Non-Aspirin Non-Steroidal Anti-Inflammatory Drugs With Colorectal Cancer Mortality After Diagnosis	23
Patient-Reported Outcomes in Pediatric Cancer Registration Trials: A US Food and Drug Administration Perspective	23
The Impact of Breast Density Information or Notification on Women’s Cognitive, Psychological, and Behavioral Outcomes: A Systematic Review	23
Distinct Reproductive Risk Profiles for Intrinsic-Like Breast Cancer Subtypes: Pooled Analysis of Population-Based Studies	23
Risk of Pancreatic Cancer in the Long-Term Prospective Follow-Up of Familial Pancreatic Cancer Kindreds	23
FOLFIRINOX as Initial Treatment for Localized Pancreatic Adenocarcinoma: A Retrospective Analysis by the Trans-Atlantic Pancreatic Surgery Consortium	23
Fibroblast subsets in non-small cell lung cancer: Associations with survival, mutations, and immune features	23
Study design considerations for trials to evaluate multicancer early detection assays for clinical utility	22
Novel Biomarkers of Habitual Alcohol Intake and Associations With Risk of Pancreatic and Liver Cancers and Liver Disease Mortality	22
Invasive cervical cancer incidence following bivalent human papillomavirus vaccination: a population-based observational study of age at immunization, dose, and deprivation	22
Long-Term Outcomes With Pharmacological Ovarian Suppression During Chemotherapy in Premenopausal Early Breast Cancer Patients	22
Racial and Ethnic Differences in Multigene Hereditary Cancer Panel Test Results for Women With Breast Cancer	22
Germline SUCLG2 Variants in Patients With Pheochromocytoma and Paraganglioma	22
Molecular Features and Functional Implications of Germline Variants in Triple-Negative Breast Cancer	21
Central Adiposity and Subsequent Risk of Breast Cancer by Menopause Status	21
Food Insecurity Among People With Cancer: Nutritional Needs as an Essential Component of Care	21
Digital Health Applications in Oncology: An Opportunity to Seize	21
Cancer Incidence in World Trade Center Rescue and Recovery Workers: 14 Years of Follow-Up	21
Breast and Prostate Cancer Risks for MaleBRCA1andBRCA2Pathogenic Variant Carriers Using Polygenic Risk Scores	21
Incidence of in Situ vs Invasive Melanoma: Testing the “Obligate Precursor” Hypothesis	20
21-Gene Assay and Breast Cancer Mortality in Ductal Carcinoma In Situ	20
Ethylene oxide emissions and incident breast cancer and non-Hodgkin lymphoma in a US cohort	20
Housing and Cancer Care and Outcomes: A Systematic Review	20
Subsequent Primary Cancer Risk Among 5-Year Survivors of Adolescent and Young Adult Cancers	20
Polygenic risk of any, metastatic, and fatal prostate cancer in the Million Veteran Program	20
Trends in the incidence of young-onset colorectal cancer with a focus on years approaching screening age: A population-based longitudinal study	20
Grade Migration of Prostate Cancer in the United States During the Last Decade	20
Interpreting cancer incidence trends: challenges due to the COVID-19 pandemic	20
Impact of HIV on Anal Squamous Cell Carcinoma Rates in the United States, 2001-2015	20
Behavioral Research in Cancer Prevention and Control: Emerging Challenges and Opportunities	19
Metabolically (un)healthy obesity and risk of obesity-related cancers: a pooled study	19
Patient-Reported Outcomes for Tolerability Assessment in Phase I Cancer Clinical Trials	19
Cancer risks by sex and variant type in PTEN hamartoma tumor syndrome	19
Inclusion of a core patient-reported outcomes battery in adolescent and young adult cancer clinical trials	19
Ultra-processed food consumption and risk of colorectal cancer precursors: results from 3 prospective cohorts	19
Cost-Sharing and Out-of-Pocket Cost for Women Who Received MRI for Breast Cancer Screening	19
Essentialism and Exclusion: Racism in Cancer Risk Prediction Models	19
Cancer Hazard Evaluations for Contemporary Needs: Highlights From New National Toxicology Program Evaluations and Methodological Advancements	19
Decreasing Incidence of Estrogen Receptor–Negative Breast Cancer in the United States: Trends by Race and Region	19
Association of Medicaid Expansion With Cancer Stage and Disparities in Newly Diagnosed Young Adults	19
Changes in survival in de novo metastatic cancer in an era of new medicines	18
Effect of Early Palliative Care on Quality of Life of Advanced Head and Neck Cancer Patients: A Phase III Trial	18
Clonal Hematopoiesis–Associated Gene Mutations in a Clinical Cohort of 448 Patients With Ovarian Cancer	18
Recommendations for Epstein-Barr virus–based screening for nasopharyngeal cancer in high- and intermediate-risk regions	18
Red-flag signs and symptoms for earlier diagnosis of early-onset colorectal cancer	18
Longitudinal Changes in Cognitive Function in a Nationwide Cohort Study of Patients With Lymphoma Treated With Chemotherapy	18
Smoking and Incidence of Colorectal Cancer Subclassified by Tumor-Associated Macrophage Infiltrates	18

Sleep Disruption, Fatigue, and Depression as Predictors of 6-Year Clinical Outcomes Following Allogeneic Hematopoietic Cell Transplantation	18
A Randomized Trial of Telephone-Based Smoking Cessation Treatment in the Lung Cancer Screening Setting	18
Progression of Frailty in Survivors of Childhood Cancer: A St. Jude Lifetime Cohort Report	18
Dopamine Receptor Antagonists, Radiation, and Cholesterol Biosynthesis in Mouse Models of Glioblastoma	18
Body Size at Different Ages and Risk of 6 Cancers: A Mendelian Randomization and Prospective Cohort Study	17
Trends of Cancer-Related Suicide in the United States: 1999-2018	17
Effect of the p53 P72R Polymorphism on Mutant TP53 Allele Selection in Human Cancer	17
Cancer mortality rates by racial and ethnic groups in the United States, 2018-2020	17
Charting a Path Towards Asian American Cancer Health Equity: A Way Forward	17
Long-Term Risk of Ovarian Cancer and Borderline Tumors After Assisted Reproductive Technology	17
Identification of the JNK-Active Triple-Negative Breast Cancer Cluster Associated With an Immunosuppressive Tumor Microenvironment	16
Costs Around the First Year of Diagnosis for 4 Common Cancers Among the Privately Insured	16
SRGN-Triggered Aggressive and Immunosuppressive Phenotype in a Subset of TTF-1–Negative Lung Adenocarcinomas	16
COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry	16
Cervical Precancers and Cancers Attributed to HPV Types by Race and Ethnicity: Implications for Vaccination, Screening, and Management	16
Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621C	16
Impact of Blinding on Patient-Reported Outcome Differences Between Treatment Arms in Cancer Randomized Controlled Trials	16
Informing Women About Overdetection in Breast Cancer Screening: Two-Year Outcomes From a Randomized Trial	16
Speeding implementation in cancer: The National Cancer Institute’s Implementation Science Centers in Cancer Control	16
Genomic Testing in Localized Prostate Cancer Can Identify Subsets of African Americans With Aggressive Disease	15
The Survival Impact of Second Primary Lung Cancer in Patients With Lung Cancer	15
Risk Stratification for Early-Onset Colorectal Cancer Using a Combination of Genetic and Environmental Risk Scores: An International Multi-Center Study	15
An Evaluation of Sex- and Gender-Based Analyses in Oncology Clinical Trials	15
A Serum Marker for Early Pancreatic Cancer With a Possible Link to Diabetes	15
Artificial intelligence–based image analysis in clinical testing: lessons from cervical cancer screening	15
Public health opportunities resulting from sufficient HPV vaccine supply and a single-dose vaccination schedule	15
The Global Landscape of Treatment Standards for Breast Cancer	14
Patient-Reported Outcomes and Long-Term Nonadherence to Aromatase Inhibitors	14
Leadership Diversity and Development in the Nation’s Cancer Centers	14
Molecular Mechanisms of ARID5B-Mediated Genetic Susceptibility to Acute Lymphoblastic Leukemia	14
Assessment of Ovarian Function in Phase III (Neo)Adjuvant Breast Cancer Clinical Trials: A Systematic Evaluation	14
Tumor Cellularity and Infiltrating Lymphocytes as a Survival Surrogate in HER2-Positive Breast Cancer	14
Prognostic and Predictive Impact of Primary Tumor Sidedness for Previously Untreated Advanced Colorectal Cancer	14
Real-World Use of Bone-Modifying Agents in Metastatic Castration-Sensitive Prostate Cancer	14
Risk of Metabolic and Cardiovascular Adverse Events With Abiraterone or Enzalutamide Among Men With Advanced Prostate Cancer	14
Prediagnostic Inflammation and Pancreatic Cancer Survival	14
Addressing Social Determinants of Health: Now Is the Time	14
Predictive Role of CD36 Expression in HER2-Positive Breast Cancer Patients Receiving Neoadjuvant Trastuzumab	14
Financial Toxicity in Adolescent and Young Adult Cancer Survivors: Proposed Directions for Future Research	14
Implementing Modernized Eligibility Criteria in US National Cancer Institute Clinical Trials	13
Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis	13
Interactions of Age and Blood Immune Factors and Noninvasive Prediction of Glioma Survival	13
Transoral Robotic Surgery for Recurrent Tumors of the Upper Aerodigestive Tract (RECUT): An International Cohort Study	13
Comparison of Treatments for Nonmetastatic Castration-Resistant Prostate Cancer: Matching-Adjusted Indirect Comparison and Network Meta-Analysis	13
Inflammation, Attention, and Processing Speed in Patients With Breast Cancer Before and After Chemotherapy	13
Historical redlining and breast cancer treatment and survival among older women in the United States	13
Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors	13
Comparing 5-Year and Lifetime Risks of Breast Cancer using the Prospective Family Study Cohort	13
Association of Health-Care System With Prostate Cancer-Specific Mortality in African American and Non-Hispanic White Men	13
Helicobacter pylori Modulated Host Immunity in Gastric Cancer Patients With S-1 Adjuvant Chemotherapy	13
Ecological and individualistic fallacies in health disparities research	13
Use of artificial intelligence for cancer clinical trial enrollment: a systematic review and meta-analysis	13
EGFRAmplification in Metastatic Colorectal Cancer	13
Urinary Thromboxane B2 and Lethal Prostate Cancer in African American Men	13
Cardiovascular Care of the Oncology Patient During COVID-19: An Expert Consensus Document From the ACC Cardio-Oncology and Imaging Councils	13
Genetic Analysis of Lung Cancer and the Germline Impact on Somatic Mutation Burden	12
Listening to the Patient Voice Adds Value to Cancer Clinical Trials	12
Racial and Ethnic Differences in Genomic Profiling of Early Onset Colorectal Cancer	12
Changes in cancer-related mortality during the COVID-19 pandemic in the United States	12
Body mass index and molecular subtypes of colorectal cancer	12
Dose optimization during drug development: whether and when to optimize	12
Global epidemiologic patterns of oropharyngeal cancer incidence trends	12
Linear association between radioactive iodine dose and second primary malignancy risk in thyroid cancer	12
National Cancer Institute–Funded Social Risk Research in Cancer Care Delivery: Opportunities for Future Research	12
Biological and Molecular Factors Predicting Response to Adoptive Cell Therapies in Cancer	12
Obstetrical and Perinatal Outcomes in Female Survivors of Childhood and Adolescent Cancer: A Population-Based Cohort Study	12
Trade-Offs Between Harms and Benefits of Different Breast Cancer Screening Intervals Among Low-Risk Women	12
Predictors of survival to immunotherapy and chemoimmunotherapy in non-small cell lung cancer: A meta-analysis	12
Genomic Risk Score for Melanoma in a Prospective Study of Older Individuals	12
Racial survival disparities in head and neck cancer clinical trials	12
Pre-Existing Autoimmune Disease and Mortality in Patients Treated with Anti-PD-1 and Anti-PD-L1 Therapy	12
Defining Multimorbidity and Its Impact in Older United States Veterans Newly Treated for Multiple Myeloma	12
Meta-Analysis of Quality of Life in Cancer Patients Treated With Immune Checkpoint Inhibitors	12
Changes in cancer mortality after Medicaid expansion and the role of stage at diagnosis	12
DNA methylation profile in CpG-depleted regions uncovers a high-risk subtype of early-stage colorectal cancer	11
The Molecular Landscape of Pancreatobiliary Cancers for Novel Targeted Therapies From Real-World Genomic Profiling	11
The intratumor microbiome is associated with microsatellite instability	11
Medication–Associated Phthalate Exposure and Childhood Cancer Incidence	11
Measuring Clinical, Biological, and Behavioral Variables to Elucidate Trajectories of Patient-Reported Outcomes: The PROFILES Registry	11
Pancreatic Ductal Carcinoma Risk Associated With Hereditary Cancer-Risk Genes	11
Survival after introduction of adjuvant treatment in stage III melanoma: a nationwide registry-based study	11
Assessment of Caregivers’ Burden When Caring for Patients With Pancreatic and Periampullary Cancer	11
Radiotherapy-Related Dose and Irradiated Volume Effects on Breast Cancer Risk Among Hodgkin Lymphoma Survivors	11
Development and Validation of a Risk Prediction Model for Second Primary Lung Cancer	11
Prostate Cancer Screening Guidelines for Black Men: Spotlight on an Empty Stage	11
RE: NDRG1 in Aggressive Breast Cancer Progression and Brain Metastasis	11
Breast Cancer Screening Among Childhood Cancer Survivors Treated Without Chest Radiation: Clinical Benefits and Cost-Effectiveness	10
Neoadjuvant Immunotherapy: An Evolving Paradigm Shift?	10
Premature aging as an accumulation of deficits in young adult survivors of pediatric cancer	10
Clinical Implications of Inter- and Intratumor Heterogeneity of Immune Cell Markers in Lung Cancer	10
How Vital Are Patient-Reported Outcomes?	10
Cancer’s Lasting Financial Burden: Evidence From a Longitudinal Assessment	10
Impact of the COVID-19 Pandemic on Treatment Patterns for Patients With Metastatic Solid Cancer in the United States	10
Social Vulnerability and Risk of Nonrelapse Mortality After Allogeneic Hematopoietic Cell Transplantation	10
Whole-Exome Sequencing Study of Familial Nasopharyngeal Carcinoma and Its Implication for Identifying High-Risk Individuals	10